Insider Sale: Chief Executive Officer at CADL sold 59,379 Shares

Generated byAinvest NewsReviewed byThe Newsroom

Friday, Sep 11, 2026 8:03 pm ET1min read

CADL--

Aime Summary

- Candel TherapeuticsCADL-- CEO Tak Paul Peter sold 59,379 shares (34.4% of holdings) on Sep 11, 2026, for $620,891.

- Insiders executed 5 stock sales (no purchases) in 6 months, including $3.16M from CEO's two transactions.

- Other executives like CSO Barone and CTO Tyagarajan also sold shares totaling $389,920 in combined transactions.

- CEO now holds 113,321 shares post-sale, raising questions about insider confidence and corporate governance.

Tak Paul Peter, a Chief Executive Officer at Candel TherapeuticsCADL-- (NASDAQ: CADL), sold 59,379 shares of the company on Sep 11, 2026 for an estimated $620,891. This was a sale of approximately 34.4% of their shares of this class of stock. Following this trade, they now own 113,321 shares of this class of $CADL stock.

Candel Therapeutics Insider Trading Activity

Candel Therapeutics insiders have traded CADLCADL-- stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of CADL stock by insiders over the last 6 months:

Tak Paul Peter (Chief Executive Officer) has made 0 purchases and 2 sales selling 280,245 shares for an estimated $3,160,783.
Barone Francesca (Chief Scientific Officer) sold 23,447 shares for an estimated $235,769.
Tyagarajan Seshu (Chief Technology Officer) has made 0 purchases and 2 sales selling 14,000 shares for an estimated $154,151.

Ainvest News

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue